Share This Article:

Serum C reactive protein level in type 2 diabetes mellitus patients attending diabetic clinic in Benin City, Nigeria

Abstract Full-Text HTML Download Download as PDF (Size:153KB) PP. 168-171
DOI: 10.4236/jdm.2013.34026    4,128 Downloads   6,895 Views   Citations

ABSTRACT

C reactive protein is sensitive physiological biomarkers of sub clinical inflammation associated with hyperglycemia. The aim of this study is to determine the fasting serum C reactive protein level in type 2 diabetes mellitus patients attending diabetic clinic in Benin City, Nigeria. The population sample consists of 142 subjects. 71 patients were known type 2 diabetes mellitus, while the other 71 were age matched control subjects. Fasting glucose and C reactive protein were estimated using glucose oxidase method and ELISA method respectively. The age group that has the highest number of type 2 diabetes mellitus was 41 - 50 (64% of males and 36% of the females). Our finding revealed that C reactive protein and serum glucose level of type 2 Diabetes mellitus in both females and males show a statistically significant increase as compared with age matched Control subjects, (P < 0.05). An elevation of serum C-reactive protein was demonstrated in both males and females type 2 diabetes mellitus in Benin City, Nigeria. These data support a possible role of inflammatory biomarkers in diabetogenesis.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

Ehiaghe, A. , Agbonlahor, D. , Tatfeng, Y. , Onikepe, F. , Oviasogie, F. and Ehiaghe, J. (2013) Serum C reactive protein level in type 2 diabetes mellitus patients attending diabetic clinic in Benin City, Nigeria. Journal of Diabetes Mellitus, 3, 168-171. doi: 10.4236/jdm.2013.34026.

References

[1] Hansen, D., Dendale, P.L., Beelen, M., Jonkers, A., Mullens, A. and Coruy, L. (2010) Plasma adipokine and inflammatory marker concentrations are altered in obese, as opposed to non-obese, type 2 Diabetes patients. European Journal Applied Physiology, 109, 397-404. http://dx.doi.org/10.1007/ s00421-010-1362-5
[2] International Diabetes Federation (2011) Diabetes atlas. 5th Edition.
[3] World Health organization (1997) Expert committee on the diagnosis and classification of diabetes mellitus: Report on the diagnosis and classification of diabetes mellitus. Diabetes Care, 20, 1183-1197.
[4] World Health Organization (2003) Expert committee on the diagnosis and classification of diabetes mellitus. Follow up report on the diagnosis of diabetes mellitus. Diabetes Care, 26, 3160-3167. http://dx.doi.org/10.2337/diacare.26.11.3160
[5] Chinenye, S., Uchenna, D.I., Unachukwu, C.N., Ogbera, A.O. and Ojule, A.C. (2008) The pattern of diabetes mellitus in Rivers State, Nigeria. Nigeria Endocrine Practice, 2, 87-93.
[6] Motala, A.A. (2002) Diabetes trends in Africa. Diabetes Metabolism Research Review, 18, 514-520. http://dx.doi.org/10.1002/dmrr.284
[7] Vigan, S. (2010) Type 2 diabetes. Annals of Internal Medicine, 152, 31.
[8] Sayolah, S.H., Miret, M., Sung, J., Varas, C., Gause, D. and Brancati, F.L. (2001) Post challenge hyperglycemia and mortality in a national sample of U.S adults. Diabetes Care, 24, 1397-1402. http://dx.doi.org/10.2337/diacare.24.8.1397
[9] Motala, A.A., Esterhrizen, T. and Gouwa, E. (2008) Diabetes and other disorders of hyperglycaemia in a South African Community: Prevalence and associated risk factor. Diabetes Care, 31, 1783-1788.
[10] Shultz, D.R. and Amoid, P.L. (1990) Properties of four acute phase protein: C Reactive protein, serum amyloid. A protein, al-acid glycoprotein and fibrinogen. Arthritis & Rheumatism, 20, 129-147. http://dx.doi.org/10.1016/0049-0172(90)90055-K
[11] SU, S.C., Pei, D., Hsieh, C.H., Hsiao, F.C., Wu, C.Z. and Hung, Y.J. (2010) Circulating pro-inflammatory cytokines and adiponectic in young men with type 2 diabetes. Acta Diabetologica, 14, 190-200.
[12] Naing, L., Winn, T. and Rusli, B.N. (2006) Practical issues in calculating the sample size for prevalence studies. Archives of Orofacial Sciences, 1, 9-14.
[13] Barham, D. and Trinder, P. (1972) An improved colour reagent for the determination of blood glucose by the oxidase system. Analyst, 97, 142. http://dx.doi.org/10.1039/an9729700142
[14] Festa, A., Agustino, R.D., Howard, G., Mykkanen, L., Tracy, R.P. and Haffner, S.M. (2000) Chronic sub-clinical inflammation as part of the insulin resistance syndrome. The insulin resistances atherosclerosis study (IRAS). Circulation, 102, 42-47. http://dx.doi.org/10.1161/01.CIR.102.1.42
[15] Pradhan, A.D., Manson, J.E., Rifai, N., Buring, J.E. and Ridker, P.M. (2001) C-reactive protein, interleukin 6 and risk of developing type 2 diabetes mellitus. JAMA, 286, 327-334. http://dx.doi.org/10.1001/jama. 286.3.327
[16] Dehghan, A., Kardys, I., de Maat, M.P., Uitterlinden, A.G., Sijbrands, E.J., Bootsma, A.H., Shjnen, T., Hofman, A., Schram, M.T. and Witteman, J.C. (2007) Genetic variation, C-reactive protein level and incidence of diabetes. Diabetes, 56, 872-878. http://dx.doi.org/10.2337/db06-0922
[17] Hansen, D., Dandale, P., Beelen, M., Jonkers, R.A., Mullens, A. and Corluy, L. (2010) Plasma adipokine and inflammatory marker concentrations are altered in obese, as opposed to non-obese, type 2 diabetes patients. European Journal of Applied Physiology, 109, 297-404. http://dx.doi.org/10.1007/ s00421-010-1362-5
[18] Cleafield, M.B. (2005) C-reactive protein: A new assessment tool for cardiovascular disease. The Journal of the American Osteopathic Association, 105, 409-416.
[19] Shahedi, V., Eizadi, M., Imanipour V. and Seyedhoseini, M.A. (2011) Association of C-reactive protein with insulin resistance in type 2 diabetic. 2011 International Conference on Bioscience, Biochemistry and Bioinformatics, 5, 407-409.

  
comments powered by Disqus

Copyright © 2019 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.